FIELD: medicine.
SUBSTANCE: method involves extracting means containing a substance possessing light hydrophobic properties negatively charged at alkaline pH from tissues being homologous to tissues under treatment. The substance has molecular mass of 500-15000 Da and is capable of reducing ratio of phosphorylated adenosine phosphate to atomic oxygen quantity consumed by high-energy mitochondria at oxidative phosphorylation stage.
EFFECT: enhanced effectiveness of treatment.
18 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD AND PREPARATION FOR PATHOGENETIC THERAPY OF DISEASES DUE TO TISSUE-SPECIFIC REGULATION OF HEPATIC MITOCHONDRIAL PROCESSES (VARIANTS) | 2006 |
|
RU2309758C1 |
NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
METHOD OF CORRECTION OF DAMAGED IMMUNE HOMEOSTASIS AND DRUG | 1998 |
|
RU2168335C2 |
MEDICATION FOR TREATMENT OF HYPOXIC AND TOXIC MITOCHONDRIAL DYSFUNCTIONS AND METHOD OF ITS OBTAINING | 2008 |
|
RU2405558C2 |
7-HYDROXYCOUMARIN DERIVATIVE FOR INDUCING MITOPHAGY IN CELLS, METHOD FOR PRODUCTION AND USE THEREOF | 2022 |
|
RU2819611C1 |
ANTIHYPOXIC MEDICINAL AGENT | 2001 |
|
RU2189813C1 |
AGENT NORMALISING LIVER MITOCHONDRIA | 2011 |
|
RU2470655C1 |
COMPOSITION FOR STIMULATION OF CELLS' GROWTH AND REGENERATION (VERSIONS) AND METHOD OF COMPOSITION'S MANUFACTURE (VERSIONS) | 2008 |
|
RU2391990C1 |
METHOD FOR CORRECTING HEMORRHAGIC SHOCK | 2001 |
|
RU2191583C1 |
TARGETED NON-INVASIVE TRANSPLANTATION INTO BRAIN OF FUNCTIONALLY ACTIVE MITOCHONDRIA FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2744453C2 |
Authors
Dates
2007-08-27—Published
2005-07-14—Filed